Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study
Journal
Targeted Oncology
ISSN
1776-2596
1776-260X
Date Issued
2024
Author(s)
Fiala, Ondřej
Massari, Francesco
Basso, Umberto
Giannatempo, Patrizia
Grande, Enrique
Buti, Sebastiano
Myint, Zin W.
De Giorgi, Ugo
Pichler, Renate
Grillone, Francesco
Ürün, Yüksel
Calabrò, Fabio
Bourlon de los Ríos, María Teresa
Galli, Luca
Kanesvaran, Ravindran
Roviello, Giandomenico
Kucharz, Jakub
Rizzo, Mimma
Park, Se Hoon
Cerbone, Linda
Seront, Emmanuel
Messina, Carlo
Molina-Cerrillo, Javier
Santini, Daniele
Yano, Akihiro
Incorvaia, Lorena
Catalano, Martina
Pinto, Alvaro
Formisano, Luigi
Soares, Andrey
Facchini, Gaetano
Fornarini, Giuseppe
Poprach, Alexandr
Rebuzzi, Sara Elena
Nasso, Cecilia
Spinelli, Gian Paolo
Angel, Martin Osvaldo
Stellato, Marco
Tural, Deniz
Aurilio, Gaetano
Epstein, Ilana
Carrozza, Francesco
Marques Monteiro, Fernando Sabino
Benedetti, Giovanni
Büchler, Tomáš
Ortega, Cinzia
Zakopoulou, Roubini
Battelli, Nicola
Porta, Camillo
Bellmunt, Joaquin
Gupta, Shilpa
Santoni, Matteo
Type
Resource Types::text::journal::journal article